Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment

Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment

BACKGROUND AND OBJECTIVES: Visceral leishmaniasis (VL) is a life-threatening infection caused by Leishmania species. In Sudan, VL is caused by L donovani. Most drugs used to treat VL, especially pentavalent antimony compounds (sodium stibogluconate, SSG), are potentially hepatotoxic. A number of fat...

Full description

Bibliographic Details
Main Authors: Abubakr O. A. Adam, Mohamed M. M. Dafalla, Hatim A. A. Mohammed, Mohamed Y. Elamin, Brima M. Younis, Mona E. E. Elfaki, Ahmed M. Musa, Ahmed M. Elhassan, Eltahir A. G. Khalil
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2014-03-01
Series:Annals of Saudi Medicine
Online Access:https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2014.143

Internet

https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2014.143

Similar Items